F
Filip K. Knop
Researcher at University of Copenhagen
Publications - 523
Citations - 17834
Filip K. Knop is an academic researcher from University of Copenhagen. The author has contributed to research in topics: Type 2 diabetes & Diabetes mellitus. The author has an hindex of 61, co-authored 437 publications receiving 13614 citations. Previous affiliations of Filip K. Knop include Copenhagen University Hospital & Victor Chang Cardiac Research Institute.
Papers
More filters
Journal ArticleDOI
The Role of Glucagon in the Acute Therapeutic Effects of SGLT2 Inhibition.
Sofie Hædersdal,Sofie Hædersdal,Sofie Hædersdal,Asger Lund,Elisabeth Nielsen-Hannerup,Henrik Maagensen,Gerrit van Hall,Jens J. Holst,Filip K. Knop,Tina Vilsbøll,Tina Vilsbøll +10 more
TL;DR: The findings do not support that an S GLT2i-induced glucagonotropic effect is of importance for the glucose-lowering property of SGLT2 inhibition, and 12 patients with type 2 diabetes were subjected to a randomized, placebo-controlled, double-blinded, crossover,double-dummy study.
Journal ArticleDOI
Glucose-Dependent Insulinotropic Polypeptide Is a Pancreatic Polypeptide Secretagogue in Humans.
Simon Veedfald,Louise Vedtofte,Kirsa Skov-Jeppesen,Carolyn F. Deacon,Bolette Hartmann,Tina Vilsbøll,Tina Vilsbøll,Filip K. Knop,Mikkel B. Christensen,Jens J. Holst +9 more
TL;DR: GIP1-42 increases plasma PP secretion in healthy individuals, patients with T2D and isolated porcine pancreata, andHyperglycemia blunts the stimulatory effect of hGIP 1-42 in healthy individuals, but not in patients with type 2 diabetes.
Journal ArticleDOI
Revisiting the role of glucagon in health, diabetes mellitus and other metabolic diseases
Journal ArticleDOI
Effect of bile acid sequestrants on glycaemic control: protocol for a systematic review with meta-analysis of randomised controlled trials
Morten Bagge Hansen,David P. Sonne,Kristian Hallundbæk Mikkelsen,Lise Lotte Gluud,Tina Vilsbøll,Filip K. Knop +5 more
TL;DR: A systematic review with meta-analysis of the glucose-lowering effect of BASs with the aim of evaluating their potential as glucose- Lowering agents in patients with type 2 diabetes mellitus.
Journal ArticleDOI
Safety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trial.
Martin L. Kårhus,Andreas Brønden,Julie Lyng Forman,Anne Haaber,Elisabeth Knudsen,Ebbe Langholz,Lars O. Dragsted,Svend Høime Hansen,Martin Krakauer,Tina Vilsbøll,David P. Sonne,Filip K. Knop +11 more
TL;DR: In this article , the safety and efficacy of liraglutide for the treatment of bile acid diarrhoea was investigated in a randomized, double-blind, active-comparator, doubledummy, non-inferiority clinical trial at the Center for Clinical Metabolic Research at Copenhagen University Hospital-Herlev and Gentofte, Hellerup, Denmark.